Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin José Luis Ordóñez, Ana Teresa Amaral, Angel M. Carcaboso, David Herrero-Martín, María del Carmen García-Macías, Vicky Sevillano, Diego Alonso, Guillem PascualPasto, Laura San-Segundo, Monica Vila-Ubach, Telmo Rodrigues, Susana Fraile, Cristina Teodosio, Agustín Mayo-Iscar, Miguel Aracil, Carlos María Galmarini, Oscar M. Tirado, Jaume Mora and Enrique de Álava